Table 1 Patient’s characteristic, overall and according to the treatment arms
Variable | Overall No (%) | Arm A FEC → TAXNo (%) | Arm B TAX → FECNo (%) |
|---|---|---|---|
Total | 119 (100) | 62 (52) | 57 (48) |
Age | Â | Â | Â |
 >50 | 67 (56) | 22 (36) | 30 (53) |
 ≤50 | 52 (44) | 40 (64) | 27 (47) |
Sex | Â | Â | Â |
 Female | 119 (100) | 62 (100) | 57 (100) |
 Male | 0 (0) | 0 (0) | 0 (0) |
T stage | Â | Â | Â |
 T1 | 22 (18) | 11 (18) | 11 (19) |
 T2 | 78 (65) | 41 (66) | 37 (64) |
 T3 | 19 (17) | 10 (16) | 9 (17) |
Nodal status | Â | Â | Â |
 Positive | 96 (81) | 51 (82) | 45 (78) |
 Negative | 23 (19) | 11 (18) | 12 (22) |
Histological type | Â | Â | Â |
 IDC | 108 (88.5) | 57 (92) | 51 (90) |
 ILD | 11 (11.5) | 5 (8) | 6 (10) |
Pathological grade | Â | Â | Â |
 1 or 2 | 46 (39) | 22 (36) | 24 (42) |
 3 | 73 (61) | 40 (65) | 33 (58) |
Breast cancer subtype | Â | Â | Â |
 Luminal A | 24 (20) | 10 (16) | 14 (24) |
 Luminal B | 49 (41) | 25 (40) | 24 (42) |
 HER2 | 17 (14) | 12 (19) | 5 (9) |
 TN | 29 (24) | 15 (24) | 14 (24) |
Ki67 (N = 106) |  |  |  |
 >20% | 68 (64) | 31 (57) | 37 (71) |
 ≤20% | 38 (36) | 23 (43) | 15 (29) |
Surgery | Â | Â | Â |
 Mastectomy | 56 (47) | 27 (44) | 29 (51) |
 BCS | 63 (53) | 35 (56) | 28 (49) |
Response rates | Â | Â | Â |
 pCR | 26 (22) | 14 (23) | 12 (21) |
 non pCR | 93 (78) | 48 (77) | 45 (79) |